Atherosclerosis is one of the major possible consequences of insulin resistance, obesity and T2D 3
Preferred injection sites are the abdomen (away from the navel), upper thighs, and upper arms
District Court for the Eastern District of Pennsylvania on March 28, where hundreds of similar lawsuits over Ozempic-related gastroparesis have been brought against Novo Nordisk and other manufacturers of GLP-1 receptor agonists, which are a class of drugs that includes Ozempic, Wegovy, Mounjaro, Zepbound and others, alleging the drug makers failed to adequately warn about the risk of severe gastrointestinal side effects
I dropped weight because I've been listening to my doctor a couple years I didn't
Presented for research literature review only Klotz P et al
Choosing the Right Injection Site and Technique The abdomen (at least 5 cm from the navel), outer thigh, and outer upper arm are the recommended subcutaneous injection sites